Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA

Weihong Zeng; Huan Ma; Chengchao Ding; Yunru Yang; Yong Sun; Xiaoxue Huang; Weihuang He; Yan Xiang; Yong Gao; Tengchuan Jin

doi:10.1038/s41392-021-00478-7

Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA

Weihong Zeng, Huan Ma, Chengchao Ding, Yunru Yang, Yong Sun, Xiaoxue Huang, Weihuang He, Yan Xiang, Yong Gao, Tengchuan Jin

Department of Microbiology, Immunology & Molecular Genetics

Research output: Contribution to journal › Letter › peer-review

41 Scopus citations

Original language	English (US)
Article number	35
Journal	Signal Transduction and Targeted Therapy
Volume	6
Issue number	1
DOIs	https://doi.org/10.1038/s41392-021-00478-7
State	Published - Dec 2021

ASJC Scopus subject areas

Genetics
Cancer Research

Access to Document

10.1038/s41392-021-00478-7

Cite this

@article{0e8a330122c64286b1d4569d30254910,

title = "Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA",

author = "Weihong Zeng and Huan Ma and Chengchao Ding and Yunru Yang and Yong Sun and Xiaoxue Huang and Weihuang He and Yan Xiang and Yong Gao and Tengchuan Jin",

note = "Funding Information: This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29030104), National Natural Science Fund (31870731, 31971129 and U1732109), the Fundamental Research Funds for the Central Universities, the new medical science fund of USTC, COVID-19 special task grants supported by Chinese Academy of Science Clinical Research Hospital (Hefei) with Grant Nos. YD2070002017 and YD2070002001, respectively.",

year = "2021",

month = dec,

doi = "10.1038/s41392-021-00478-7",

language = "English (US)",

volume = "6",

journal = "Signal Transduction and Targeted Therapy",

issn = "2095-9907",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA

AU - Zeng, Weihong

AU - Ma, Huan

AU - Ding, Chengchao

AU - Yang, Yunru

AU - Sun, Yong

AU - Huang, Xiaoxue

AU - He, Weihuang

AU - Xiang, Yan

AU - Gao, Yong

AU - Jin, Tengchuan

N1 - Funding Information: This work was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29030104), National Natural Science Fund (31870731, 31971129 and U1732109), the Fundamental Research Funds for the Central Universities, the new medical science fund of USTC, COVID-19 special task grants supported by Chinese Academy of Science Clinical Research Hospital (Hefei) with Grant Nos. YD2070002017 and YD2070002001, respectively.

PY - 2021/12

Y1 - 2021/12

UR - http://www.scopus.com/inward/record.url?scp=85099937008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85099937008&partnerID=8YFLogxK

U2 - 10.1038/s41392-021-00478-7

DO - 10.1038/s41392-021-00478-7

M3 - Letter

C2 - 33514692

AN - SCOPUS:85099937008

SN - 2095-9907

VL - 6

JO - Signal Transduction and Targeted Therapy

JF - Signal Transduction and Targeted Therapy

IS - 1

M1 - 35

ER -

Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this